莫诺帕制药 MNPR
$71.42 +$4.20 (+6.25%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $73.00 +2.21%
开盘$68.02
昨收$67.22
当日区间$67.31 – $72.25
成交量94.2K
市值$479.38M
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$0.00
营业利润-$6.64M-105.4% YoY
净利润-$5.31M-116.6% YoY
摊薄每股收益-$0.62-77.1% YoY
自由现金流-$3.25M-201.4% YoY
经营现金流-$3.25M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
净资产收益率-19.5%
资产收益率-18.9%
投入资本回报率-24.1%
流动比率33.56
负债/资产比率3.1%
现金及投资$134.30M
总负债$107,829.00
净现金（净负债）$134.19M
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 营业总收入 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 营业费用 | $6.64M | $5.23M | $16.70M | $6.16M | $4.09M |
| 销售及管理费用 | $1.88M | $1.74M | $6.80M | $2.21M | $1.50M |
| -管理费用 | $1.88M | $1.74M | $6.80M | $2.21M | $1.50M |
| 研发费用 | $4.77M | $3.49M | $9.90M | $3.94M | $2.59M |
| 营业利润 | -$6.64M | -$5.23M | -$16.70M | -$6.16M | -$4.09M |
| 非经营性利息净收入（支出） | $1.30M | $1.33M | $2.99M | $954,434.00 | $655,473.00 |
| 非经营性利息收入 | $1.30M | $1.33M | $2.99M | $954,434.00 | $655,473.00 |
| 其他收入（支出） | $32,158.00 | – | – | – | – |
| 其他非经营性收入（支出） | $32,158.00 | – | – | – | – |
| 税前利润 | -$5.31M | -$3.89M | -$13.72M | -$5.20M | -$3.44M |
| 净利润 | -$5.31M | -$3.89M | -$13.72M | -$5.20M | -$3.44M |
| 持续经营利润 | -$5.31M | -$3.89M | -$13.72M | -$5.20M | -$3.44M |
| 归属母公司净利润 | -$5.31M | -$3.89M | -$13.72M | -$5.20M | -$3.44M |
| 归属普通股股东净利润 | -$5.31M | -$3.89M | -$13.72M | -$5.20M | -$3.44M |
| 基本每股收益 | -$0.62 | -$0.46 | -$1.85 | -$0.64 | -$0.48 |
| 摊薄每股收益 | -$0.62 | -$0.46 | -$1.85 | -$0.64 | -$0.48 |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $134.98M | $137.98M | $140.72M | $140.72M | $144.20M |
| 流动资产合计 | $134.76M | $137.74M | $140.46M | $140.46M | $144.09M |
| 现金及现金等价物与短期投资 | $134.30M | $137.49M | $140.40M | $140.40M | $143.68M |
| -现金及现金等价物 | $52.76M | $52.54M | $61.83M | $61.83M | $127.68M |
| -短期投资 | $81.54M | $84.95M | $78.57M | $78.57M | $16.00M |
| 其他流动资产 | $464,727.00 | $250,903.00 | $63,745.00 | $63,745.00 | $414,825.00 |
| 非流动资产合计 | $215,120.00 | $239,882.00 | $254,921.00 | $254,921.00 | $106,666.00 |
| 固定资产净值 | $215,120.00 | $239,882.00 | $254,921.00 | $254,921.00 | $106,666.00 |
| -固定资产原值 | $215,120.00 | $239,882.00 | $254,921.00 | $254,921.00 | $106,666.00 |
| 负债合计 | $4.12M | $2.59M | $2.89M | $2.89M | $2.64M |
| 流动负债合计 | $4.02M | $2.46M | $2.74M | $2.74M | $2.57M |
| 应付款 | $4.02M | $2.46M | $2.74M | $2.74M | $2.57M |
| -应付账款 | $4.02M | $2.46M | $2.74M | $2.74M | $2.57M |
| 非流动负债合计 | $107,828.00 | $131,565.00 | $154,920.00 | $154,920.00 | $70,881.00 |
| 长期债务及融资租赁负债 | $107,829.00 | $131,565.00 | $154,920.00 | $154,920.00 | $70,881.00 |
| -长期融资租赁负债 | $107,829.00 | $131,565.00 | $154,920.00 | $154,920.00 | $70,881.00 |
| 其他非流动负债 | -$1.00 | – | – | – | – |
| 股东权益合计 | $130.85M | $135.39M | $137.83M | $137.83M | $141.56M |
| 股东权益 | $130.85M | $135.39M | $137.83M | $137.83M | $141.56M |
| 股本 | $6,712.00 | $6,699.00 | $6,692.00 | $6,692.00 | $6,663.00 |
| -普通股 | $6,712.00 | $6,699.00 | $6,692.00 | $6,692.00 | $6,663.00 |
| 资本公积 | $229.47M | $228.69M | $227.20M | $227.20M | $225.85M |
| 留存收益 | -$98.72M | -$93.40M | -$89.51M | -$89.51M | -$84.31M |
| 不影响留存收益的损益 | $91,317.00 | $98,521.00 | $131,389.00 | $131,389.00 | $11,698.00 |
| 一年内应计费用 | – | – | $0.00 | $0.00 | $0.00 |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$3.25M | -$3.47M | -$12.20M | -$3.37M | -$2.09M |
| 持续经营经营活动现金流净额 | -$3.25M | -$3.47M | -$12.20M | -$3.37M | -$2.09M |
| 持续经营净利润 | -$5.31M | -$3.89M | -$13.72M | -$5.20M | -$3.44M |
| 营运资金变动 | $1.35M | -$474,202.00 | -$2.61M | $1.44M | $33,833.00 |
| -应付账款及应计费用变动 | $1.56M | -$287,138.00 | -$2.61M | $738,682.00 | $355,101.00 |
| -其他流动资产变动 | -$213,822.00 | -$187,039.00 | $15,404.00 | $709,403.00 | -$321,268.00 |
| -其他营运资金变动 | $0.00 | -$25.00 | -$9,432.00 | -$5,002.00 | $0.00 |
| 投资活动现金流净额 | $4.12M | -$5.58M | -$63.45M | -$62.19M | -$2.13M |
| 持续经营投资活动现金流净额 | $4.12M | -$5.58M | -$63.45M | -$62.19M | -$2.13M |
| 投资购置及出售净额 | $4.12M | -$5.58M | -$63.45M | -$62.19M | -$2.13M |
| 筹资活动现金流 | -$647,389.00 | -$200,203.00 | $91.57M | -$384,680.00 | $92.39M |
| 持续经营筹资活动现金流净额 | -$647,389.00 | -$200,203.00 | $91.57M | -$384,680.00 | $92.39M |
| 股票期权行使所得 | $7,575.00 | $0.00 | $565,171.00 | $544,800.00 | $214.00 |
| 其他筹资费用净额 | -$654,964.00 | -$200,203.00 | -$1.13M | -$298,094.00 | -$381,563.00 |
| 期末现金余额 | $52.76M | $52.54M | $61.83M | $61.83M | $127.68M |
| 现金净变动 | $220,645.00 | -$9.26M | $15.92M | -$65.94M | $88.18M |
| 期初现金余额 | $52.54M | $61.83M | $45.82M | $127.68M | $39.50M |
| 汇率变动影响 | -$7,142.00 | -$31,628.00 | $97,266.00 | $99,495.00 | $376.00 |
| 自由现金流 | -$3.25M | -$3.47M | -$12.20M | -$3.37M | -$2.09M |
| 普通股发行净额 | – | – | $92.14M | -$631,386.00 | – |
暂无评论——快来第一个聊聊 MNPR。
登录后参与讨论。